Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Associate Director, Marketing will serve as the commercial lead for Hepatitis Delta (HDV) diagnostics and patient finding, with responsibility for building scalable capabilities that increase testing, identify undiagnosed patients, understand ‘diagnostic leakage’ and improve the pathway from diagnosis through referral to appropriate care.
This role will focus on building sustainable patient-identification infrastructure across the HDV diagnostic and referral systems helping translate pre-launch investment into a more visible, connected and launch-ready patient population. The Associate Director will lead commercial initiatives designed to increase HDV testing, expand appropriate reflex and double-reflex testing approaches, reduce barriers within the diagnostic journey, and accelerate identification of patients living with HDV.
The Associate Director will serve as a key leader in U.S. HDV market development, identifying structural barriers to diagnosis and developing scalable solutions that improve patient identification and strengthen diagnostic and referral pathways. Working closely with Brand Marketing, Medical Affairs, Advocacy, Commercial Analytics, Field Teams, Market Access, and other cross-functional partners, the Associate Director will translate market, customer, diagnostic, and community insights into actionable programs. The role will also build strategic partnerships with diagnostic laboratories, health systems, community organizations, and other external stakeholders to develop and scale innovative approaches to patient identification.
This role is ideal for a strategic, entrepreneurial, analytical, and highly collaborative professional who is comfortable building new capabilities, testing innovative approaches, and driving initiatives from strategy through execution and measurement.
JOB FUNCTIONS/RESPONSIBILITIES
• Develop and maintain a multi-year HDV patient-identification and diagnostics roadmap, prioritizing initiatives based on patient impact, scalability, feasibility, investment requirements, and contribution to U.S. launch readiness.
• Lead the development and execution of the U.S. commercial diagnostics and patient-finding strategy for HDV, with accountability for increasing testing, diagnosis, and linkage to appropriate care.
• Develop implementation frameworks that enable health systems and laboratory partners to operationalize and sustain appropriate HDV testing pathways, including workflow redesign, stakeholder engagement, education, technology enablement and performance measurement.
• Lead commercial initiatives designed to increase adoption of appropriate HDV testing approaches, including reflex and double-reflex testing within health systems and laboratory workflows.
• Build and manage strategic partnerships with national and regional diagnostic laboratories, health systems, and other testing organizations to expand access to and simplify HDV testing.
• Identify barriers and develop scalable diagnostic solutions that improve testing workflows and enable more consistent identification of patients with HDV.
• Lead innovative patient-finding pilots utilizing appropriate data and technology, including electronic medical records, claims data, population-health approaches, and other emerging capabilities.
• Partner with Commercial Analytics to ident
Apply on employer site ↗